On one hand, it interferes with polyamine synthesis by reducing the activity of ornithine decarboxylase (ODC), while on the other hand, it inhibits the uptake of polyamines [68,69]; this interference in turn leads to the suppression of tumour cell proliferation in vitro [57,70]. The gene discussed is ODC1; the disease is neoplasm.